AI drug-development startup Orchestra Bio joins OpenAI after four years
kevinakwok · x · 2026-10-21
Ashok Raj announced that Orchestra Bio — founded four years ago to help biotech and pharma teams advance drug development programs — is joining OpenAI. He said AI has reached an inflection point where people and agents can take on drug development together, and joining OpenAI lets the team continue the mission at greater scale. The deal signals OpenAI's continued push into AI for science and life sciences.
Related event: OpenAI Acquires Orchestra Bio to Double Down on AI-Driven Drug Development(9 posts)→
More from Companies & People
- Robotics research meetup 'Paper and Pizza' in SF tomorrow, hosted for local researchers — arankomatsuzaki · 2026-10-21
- PM OS vs Team OS vs Company OS: how to layer your AI setup and which to build first — aakashgupta · 2026-10-21
- Technically Speaking podcast launches with Databricks, WorkOS, Datadog founders for Season 1 — jamesmurdza · 2026-10-21
- GitHub HQ Hosts Open Source AI + Policy Talk with Mozilla Co-founder Mitchell Baker — kevinsxu · 2026-10-21
- Affiniti Pivots Into an AI-Native Operating System for 3,300+ Main Street Businesses — jfiance · 2026-10-21
- CodeRabbit Ships 5,000 PRs a Week With a Tiny Team, Hires by Strategy-Game Hours — omojumiller · 2026-10-21